| Ajaz Bashir Sheikh, | |
|
1135 16th Ave Ne, Suite 570, Bellevue, WA 98004-4632 | |
| (425) 454-4768 | |
| (425) 462-8021 |
| Full Name | Ajaz Bashir Sheikh |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1135 16th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053896050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP60994938 (Washington) | Primary |
| Entity Name | Paceline Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417273780 PECOS PAC ID: 5799853099 Enrollment ID: O20081013000526 |
News Archive
A team of engineering researchers at the Georgia Institute of Technology hopes to uncover new ways to diagnose and treat brain ailments, from tumors and stroke to Parkinson's disease, leveraging vibrations and ultrasound waves.
A new online learning module, Managing hepatitis C in primary care, provides GPs with an update on the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 7 days ago
| Entity Name | Anesthesia Associates Northwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548281751 PECOS PAC ID: 7618908484 Enrollment ID: O20161115001177 |
News Archive
A team of engineering researchers at the Georgia Institute of Technology hopes to uncover new ways to diagnose and treat brain ailments, from tumors and stroke to Parkinson's disease, leveraging vibrations and ultrasound waves.
A new online learning module, Managing hepatitis C in primary care, provides GPs with an update on the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 7 days ago
| Entity Name | Washington Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306364401 PECOS PAC ID: 6204194848 Enrollment ID: O20180103000884 |
News Archive
A team of engineering researchers at the Georgia Institute of Technology hopes to uncover new ways to diagnose and treat brain ailments, from tumors and stroke to Parkinson's disease, leveraging vibrations and ultrasound waves.
A new online learning module, Managing hepatitis C in primary care, provides GPs with an update on the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ajaz Bashir Sheikh, 3209 S 23rd St Ste 200, Tacoma, WA 98405-1602 Ph: (253) 272-5127 | Ajaz Bashir Sheikh, 1135 16th Ave Ne, Suite 570, Bellevue, WA 98004-4632 Ph: (425) 454-4768 |
News Archive
A team of engineering researchers at the Georgia Institute of Technology hopes to uncover new ways to diagnose and treat brain ailments, from tumors and stroke to Parkinson's disease, leveraging vibrations and ultrasound waves.
A new online learning module, Managing hepatitis C in primary care, provides GPs with an update on the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 7 days ago
Mr. Timothy Joseph Riley, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 | |
Sharon Marie Amaya Ii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 227 Bellevue Way Ne # 188, Bellevue, WA 98004 Phone: 888-337-3509 Fax: 866-472-1356 | |
Ms. Mandalyn Musselman, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 | |
Dr. Katherine Christine Kuhlmann, CRNA, DNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 844-620-1839 | |
Bradley Allen Johnson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 | |
Diane Kastens, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 |